EU regulator backs use of Novo's Wegovy for obesity-related heart condition

cafead

Administrator
Staff member
  • cafead   Sep 19, 2024 at 09:32: PM
via The European Medicines Agency backed the use of Novo Nordisk's (NOVOb.CO), opens new tab popular drug Wegovy to help ease heart failure in people with obesity, the Danish drugmaker said on Thursday.

article source